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Abstract  16 
Background: Limited evidence suggests that physical activity has beneficial effects in people with 17 
inflammatory bowel disease (IBD). This study aimed to determine the physical activity habits of 18 
adults with IBD, the limitations to physical activity they experience because of their disease, and the 19 
extent to which their physical activity is affected by various demographic, clinical and psychological 20 
factors. 21 
Methods: Data were collected on 859 adult participants (52% with Crohn’s disease [CD], 75% 22 
female) via an online survey conducted between May and June 2016. Measures included physical 23 
activity (International Physical Activity Questionnaire), psychological symptoms (Hospital Anxiety 24 
and Depression Scale), fatigue (sub-items of IBD fatigue scale), exercise perceptions (Exercise 25 
Benefits/Barriers Scale) and disease activity. Regression analyses were used to identify predictors of 26 
physical activity. 27 
Results: Only 17% of respondents were categorised as “high active”. Self-reported physical activity 28 
levels decreased, and fatigue and psychological scores increased, with increasing disease activity. 29 
Walking was the most common activity performed (57% of respondents) and running/jogging the 30 
most commonly avoided (34%). Many participants (n=677) reported that IBD limited their physical 31 
activity for reasons including abdominal/joint pain (70%), fatigue/tiredness (69%), disease flare-up 32 
(63%), and increased toilet urgency (61%). Physical activity was independently associated with 33 
depression, disease activity and perceived barriers to exercise in people with CD, and depression and 34 
age in people with ulcerative or indeterminate colitis (all P≤0.038).  35 
Conclusions: This survey highlights several important factors that should be considered by designers 36 
of future physical activity interventions for people with IBD.  37 
 38 
Key Words: Crohn’s disease; exercise; depression; fatigue; physical activity; ulcerative colitis   39 
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1. Introduction 40 
Physical activity and exercise are important lifestyle behaviours for the general population: they are 41 
associated with improvements in physical fitness and mental well-being (1, 2); they facilitate weight 42 
management (3); and, independently of these benefits, they have been associated with lower 43 
mortality rates (4). Physical activity/exercise may also be a useful adjunctive therapy for people with 44 
inflammatory bowel disease (IBD) by improving immune function and mood, reducing fatigue, and 45 
promoting gains in muscle and bone strength (5). However, the evidence for physical 46 
activity/exercise in IBD is sparse, with only a handful of intervention studies (6-9), some of which 47 
have methodological limitations such as short follow-up, no control group, and a small sample size. 48 
As such, it is perhaps unsurprising that there are currently no evidence-based physical activity 49 
guidelines that are specific to IBD.  50 
 51 
Despite the numerous potential benefits of physical activity, there is evidence that a large 52 
proportion of the IBD population is physically inactive, and that people with IBD are less active than 53 
people without IBD (10, 11). Although the reasons for this are unclear, recent surveys have 54 
demonstrated that many patients cite limitations to physical activity due to IBD-related factors such 55 
as fatigue, joint pain, and lack of toilet access (12, 13). There is also evidence from other populations 56 
that depression disorders and symptoms, which have a reported prevalence in IBD of 15.2% and 57 
21.6%, respectively (14), may have an adverse impact on self-management behaviours such as 58 
physical activity (15). A better understanding of the modifiable correlates of physical activity in 59 
people with IBD will aid in the development of interventions with the potential to favourably-modify 60 
behavioural and health outcomes.  61 
 62 
Given the lack of research in this area, the purpose of this study was to characterise the physical 63 
activity habits of adults with IBD, to explore limitations to physical activity that patients may face 64 
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because of their disease, and to identify factors that are associated with physical activity. An 65 
additional objective was to explore clinical and psychological correlates of fatigue.  66 
  67 
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2. Materials and Methods 68 
2.1 Ethics approval 69 
The study was approved by the Northumbria University Faculty of Health and Life Sciences Research 70 
Ethics Committee in May 2016.  71 
 72 
2.2 Design 73 
A cross-sectional online survey was conducted. 74 
 75 
2.3 Participants 76 
Participants were a non-clinical population recruited via on-line advertisements on Twitter, 77 
Facebook and Instagram. They were invited to participate if they had a formal diagnosis of IBD and 78 
were at least 18 years of age. Respondents who were younger than 18 years old were excluded. 79 
 80 
2.4 Procedure 81 
The survey was conducted between May and June 2016. The link to the survey was included in the 82 
advertisements and interested respondents answered the survey directly through this link. 83 
Survey Monkey was used as it allowed confidential access and facilitated data analysis. Study 84 
information was provided at the commencement of the survey, and respondents had to provide 85 
informed consent before they could participate. Contact details of the researchers were provided in 86 
case any queries arose. 87 
 88 
2.5 Survey 89 
The survey was anonymous. The first section collected participants’ age, gender, employment status, 90 
smoking status, and whether they Crohn’s disease (CD), ulcerative colitis (UC) or indeterminate 91 
colitis (IC). The second section assessed duration of diagnosis, current treatments, surgical history, 92 
disease activity, depression and anxiety symptoms, and fatigue. For people with CD, disease activity 93 
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was assessed using the PRO3 Index, with scores of <13, 13-21, 22-52 and ≥52 indicative of inactive, 94 
mildly active, moderately active, and severely active disease, respectively (16). For people with UC or 95 
IC, disease activity was assessed using the Patient-based Simple Clinical Colitis Activity Index (P-96 
SCCAI), with scores of <5 and ≥5 indicative of inactive and active disease, respectively (17). 97 
Depression and anxiety symptoms were measured by using the Hospital Anxiety and Depression 98 
Scale (HADS) (18). Fatigue was assessed using items 4 and 5 of the IBD Fatigue Scale (19): “What was 99 
your AVERAGE fatigue level in the past two weeks?” (5-point ordinal scale ranging 0 [No fatigue] to 4 100 
[Severe fatigue]) and “How much of your waking time have you felt fatigued in the past two weeks” 101 
(5-point ordinal scale ranging 0 [None of the time] to 4 [All of the time]). A composite fatigue score 102 
was calculated by multiplying the responses to these two questions. The third section of the survey 103 
assessed participants’ physical activity habits using the International Physical Activity Questionnaire 104 
(IPAQ) – Short Form (20). Standard scoring criteria were used (http://www.ipaq.ki.se) to classify 105 
respondents as ‘inactive’, ‘minimally active’ or ‘HEPA active’ (health enhancing physical activity; a 106 
high activity category). Standard formulae were also used to produce a continuous indicator of 107 
physical activity; a total physical activity score in MET-min/week, computed as the sum of walking, 108 
moderate, and vigorous MET-min/week scores (http://www.ipaq.ki.se). Participants were also asked 109 
to list up to 3 types of physical activity, exercise or sport that they most frequently participated in 110 
over the past year, and up to 3 types of physical activity, exercise or sport that they avoided because 111 
of their IBD in the past year. The final section of the survey assessed participants’ perceived benefits 112 
and barriers to exercise using the Exercise Benefits/Barriers Scale (21), and their reasons (if 113 
applicable) for IBD limiting participation in physical activity. 114 
 115 
2.6 Statistical analysis 116 
All responses collected via Survey Monkey were inspected, downloaded into Excel, coded and 117 
analysed using descriptive statistics (means, standard deviations [SD], medians, interquartile ranges 118 
[IQR], frequencies, and percentages). All returned surveys were included in the analysis, regardless 119 
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of the amount of missing data. Consequently, the number of total responses for each survey item 120 
varied due to missing data and refusal/inability to answer.  121 
 122 
Multivariable linear regression analyses were conducted to determine the combination of clinical 123 
and psychological indices that best explained the observed variations in physical activity and fatigue 124 
scores. Separate models were constructed for people with CD and people with UC or IC (combined). 125 
Inspection of the total physical score in MET-min/week demonstrated significant positive skew that 126 
was transformed to a normal distribution using logarithmic transformation. The fatigue composite 127 
score was treated as a continuous outcome, and inspection of the histogram demonstrated an 128 
approximately normal distribution.  129 
 130 
A multi-stage strategy was used to develop our explanatory models. Firstly, correlation matrices 131 
were produced to explore the relationship between dependent variables (physical activity and 132 
fatigue) and potential predictor variables (age, gender, disease severity, disease duration, 133 
depression, anxiety, exercise barriers score, and exercise benefits score). Indices that demonstrated 134 
significant correlation (two-tailed p<0.05) with the dependent variable were then carried forward for 135 
inclusion in a ‘stage 1’ multivariable linear regression model. The final model was then constructed, 136 
retaining only those coefficients making a significant (p<0.05) contribution to the overall model fit. 137 
Analyses were conducted using IBM SPSS Statistics Version 22 (IBM United Kingdom Limited, 138 
Hampshire, UK). 139 
 140 
  141 
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3. Results 142 
3.1 Participant characteristics 143 
Overall, there were 859 eligible respondents to the survey, of whom 75.2% were female (Table 1). 144 
The mean (SD) age was 37.3 (11.6) years, 52% had CD, and the median (IQR) time since diagnosis 145 
was 87 (36 to 178) months. According to the PRO3 Index data, 28.3% of people with CD were in 146 
clinical remission, and 19.0%, 45.1% and 7.6% had mildly-, moderately-, or severely-active disease, 147 
respectively. Using the P-SCCAI data, 40.7% of people with UC or IC had inactive disease, and 59.3% 148 
had active disease. Table 2 shows data on current treatments and surgical history. 149 
 150 
3.2 Physical activity habits and limitations 151 
Of the 737 respondents who completed the IPAQ, 17.1% were classified as HEPA (i.e., high) active, 152 
49.6% as minimally active, and 33.3% as inactive (Table 3). The median total physical activity was 153 
1866 (594 to 4040) MET·min/week and mean daily sitting time was 429 (225) min. The proportion of 154 
physically-inactive individuals increased, in both disease sub-groups, with increasing disease activity. 155 
For example, 21.7% of people with mildly-active CD reported being physically inactive versus 62.1% 156 
of people with severely-active CD. The exercise barriers scores also increased, and the exercise 157 
benefits scores decreased, with increasing disease activity (Table 3).  158 
 159 
Figure 1A shows that the respondents had participated in a wide range of activities/exercises in the 160 
past year, with walking being the most common activity by far (56.7%). There were no marked 161 
differences between disease sub-types. Similarly, the types of activity/exercise that were avoided 162 
because of IBD did not differ markedly between CD and UC/IC respondents (Figure 1B). Of the 712 163 
respondents, running/jogging was the most commonly avoided activity (32.2%).  164 
 165 
Six hundred and seventy-seven participants (79%) reported that their IBD limited their participation 166 
in physical activity/exercise (Figure 2). The most common reasons were abdominal or joint pain (n = 167 
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473), fatigue or tiredness (n = 471), disease flare-up (n = 430), and increased toilet urgency (n = 411). 168 
The proportion of respondents providing reasons tended to be higher in CD versus UC/IC (e.g., 80.9% 169 
vs. 57.1% for abdominal or joint pain; 84.3% vs. 52.7% for fatigue or tiredness). 170 
 171 
3.3 Depression, anxiety and fatigue 172 
Of the whole IBD cohort, 33.1% and 22.3% of respondents had abnormal anxiety and depression 173 
scores (i.e., HADS scores of 11 to 21), respectively. The anxiety and depression scores were generally 174 
higher in CD versus UC/IC, with higher scores also seen in individuals with more-active disease (Table 175 
3). 176 
 177 
Data on average fatigue levels in the past two weeks is presented in Figure 3. Fatigue scores were 178 
generally worse in people with CD, in females, in people with higher levels of disease activity, and in 179 
people with lower levels of physical activity. For example, “severe fatigue” was more frequently 180 
reported in people with CD than people with UC/IC (26.8% vs. 20.1%), in females than males (CD: 181 
27.3% vs. 25.5%; UC/IC: 20.8% vs. 11.5%), and in physically-inactive individuals than high-active 182 
individuals (CD: 33.8% vs. 19.0%; UC/IC: 38.5% vs. 9.4%).  183 
 184 
3.4 Predictors of physical activity and fatigue 185 
Table 4 shows the correlations between physical activity, fatigue and various demographic, clinical 186 
and psychological factors. In people with CD, variables that were significantly correlated with 187 
logarithmically-transformed total physical activity were disease activity (r = -0.228, P<0.01), 188 
depression (r = -0.287, P<0.01), anxiety (r = -0.120, P<0.05), fatigue (r = -0.127, P<0.05), exercise 189 
benefits score (r = 0.244, P<0.01), and exercise barriers score (r = -0.292, P<0.01), whereas variables 190 
that were significantly correlated with fatigue were duration of diagnosis (r = 0.110, P<0.05), disease 191 
activity (r = 0.479, P<0.01), depression (r = 0.538, P<0.01), anxiety (r = 0.465, P<0.01), and physical 192 
activity (r = -0.127, P<0.05). In people with UC/IC, variables that were significantly correlated with 193 
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logarithmically-transformed total physical activity were age (r = -0.158, P<0.01), disease activity (r = -194 
0.123, P<0.05), depression (r = -0.240, P<0.01), fatigue (r = -0.181, P<0.01), and exercise benefits 195 
score (r = 0.171, P<0.01) , whereas variables that were significantly correlated with fatigue were 196 
disease activity (r = 0.393, P<0.01), depression (r = 0.572, P<0.01), anxiety (r = 0.453, P<0.01), and 197 
physical activity (r = -0.181, P<0.01). 198 
 199 
The multivariable linear regression models for physical activity and fatigue are shown in Tables 5 and 200 
6, respectively. After adjusting for each of the included demographic, clinical and psychological 201 
factors, several variables were found to be independently associated with low physical activity levels 202 
including higher disease activity (B = -0.010, P=0.038), depression (B = -0.077, P=0.002) and exercise 203 
barriers (B = -0.035, P=0.008) scores for people with CD, and higher age (B = -0.016; P=0.011) and 204 
depression score (B = -0.053, P=0.025) for people with UC/IC. In the final models, these factors 205 
explained 12.3% and 7.3% of the observed variability in self-reported total physical activity in the CD 206 
and UC/IC groups, respectively.  207 
 208 
Variables that were found to be independently associated with higher fatigue scores were longer 209 
time since diagnosis (B = 0.005, P=0.011), and higher disease activity (B = 0.076, P<0.001), 210 
depression (B = 0.324, P<0.001) and anxiety (B = 0.183, P=0.001) scores in people with CD, and 211 
female gender (B = -1.360; P=0.006), and higher depression (B = 0.454; P<0.001) and anxiety (B = 212 
0.180; P=0.003) scores in people with UC/IC. In the final models, these factors explained 37% and 213 
36% of the observed variability in self-reported fatigue in the CD and UC/IC groups, respectively. 214 
  215 
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4. Discussion 216 
The main novel finding from this cross-sectional online survey was that physical activity was 217 
negatively and independently associated with depression, disease activity and exercise barriers in 218 
people with CD, and depression and age in people with UC/IC. Other key findings are as follows: the 219 
large majority of respondents, regardless of disease type, did not engage in physical activity at levels 220 
commensurate with public health guidelines; physical activity levels were lower and fatigue and 221 
psychological scores higher in people with higher levels of disease activity; walking was by far the 222 
most common type of physical activity performed, with running/jogging the most common activity 223 
avoided because of IBD; a large proportion of respondents provided reasons for IBD limiting their 224 
participation in physical activity, including pain, fatigue, flare-up and increased toilet urgency, and; 225 
independent predictors of fatigue were time since diagnosis, disease activity, depression and anxiety 226 
in people with CD, and gender, depression and anxiety in people with UC/IC.    227 
 228 
There is a paucity of published data on predictors of physical activity in people with IBD. In a recent 229 
study in which 7-day accelerometry was used to objectively measure physical activity in 48 adults 230 
with CD, low body mass index (<21 kg/m2), longer time since diagnosis, presence of systemic 231 
inflammation (indicated by serum C-reactive protein >3 mg/L) and low vitamin D3 (<50 nmol/L) were 232 
all independently associated with lower physical activity (zero bouts of moderate-to-vigorous 233 
physical activity during the 7-day accelerometer-wear period) (11). Unfortunately, the authors did 234 
not report how much of the variation in physical activity was explained by these variables. Of these 235 
predictor variables, only time since diagnosis was recorded in the current study, and we did not 236 
observe a significant association (Table 4). The reason for this discrepancy is unclear, but may be due 237 
to differences in the study populations and the way physical activity was measured and classified. In 238 
the present study, although large amounts of the variability in total physical activity remained 239 
unexplained by the regression models, it was notable that depressed mood emerged as being 240 
independently associated with less physical activity in both CD and UC/IC sub-groups. Such an 241 
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association, which has previously been reported for adults with type 2 diabetes (22), might be 242 
explained by depressed mood having an adverse impact on self-management behaviours (15); 243 
however, the evidence from randomised controlled trials is currently equivocal as to whether 244 
depression-specific management in depressed individuals leads to increased physical activity (23, 245 
24). We acknowledge that cross-sectional studies cannot assign causality and highlight that the 246 
inverse association between physical activity and depressed mood is likely bi-directional (25). 247 
Viewed this way, our findings may suggest a potential beneficial effect of regular physical activity on 248 
depressive symptoms in people with IBD. A recent meta-analysis of 35 randomised controlled trials 249 
(n=1356) showed that exercise training is moderately more effective than a control intervention for 250 
reducing symptoms of depression in adults with depression (2); however we are not aware of any 251 
prospective trials that have explored the potential mental health benefits of exercise training in 252 
people with IBD specifically. Given that a relatively high proportion of people with IBD have 253 
abnormal depression scores (22.3% in the current study), this seems an important area of focus for 254 
future research, and we are currently exploring the effects of continuous and interval-type aerobic 255 
exercise training on physical fitness, fatigue, mental well-being and disease activity in people with 256 
inactive or mildly-active CD (26). Future studies, are also needed to better understand the sources of 257 
the unexplained variance in physical activity. Such studies should ideally be prospective, include 258 
objective measurement of physical activity, and include a range of intrapersonal, social and physical 259 
environmental predictor variables. 260 
 261 
Few studies have explored the physical activity habits and limitations of people with IBD (10, 12, 13), 262 
but such information has practical value in the promotion of physical activity in this population. In 263 
this study, walking was the most common form of physical activity that the respondents participated 264 
in within the last year. Indeed, 57% of respondents cited walking, whereas the next most common 265 
activities of cycling, running, swimming, and gym were each cited by less than 20% of respondents. 266 
This finding is consistent with previous research that has demonstrated walking to be the most 267 
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common recreational and sporting activity undertaken by the general adult population (27) and 268 
people with IBD (10, 12). Health promotion initiatives seeking to engage people with IBD in physical 269 
activity need to be sensitive to the preferred mode of physical activity when designing interventions. 270 
Achieving a better understanding of physical activity levels may also represent a meaningful step in 271 
health promotion efforts in this population. Although 83% of all respondents indicated having 272 
undertaken one or more forms of physical activity in the last year, the IPAQ data showed that the 273 
same proportion (i.e., 83%) was classified as either “minimally-active” or “inactive”. When compared 274 
against the results of the International Prevalence Study on Physical Activity (28), which also used 275 
the IPAQ short form to quantify physical activity levels, our findings suggest that people with IBD 276 
(and particularly those with more highly-active disease) are substantially less physically active than 277 
the general adult population. For example, 17% of our survey respondents were in the high physical 278 
activity category versus 62% of adults aged 18-65 years in the USA (28). The reasons for this are not 279 
fully understood, but might at least be partly explained by the fact that many people reported 280 
experiencing IBD-related limitations to physical activity such as pain, fatigue, disease flare-up and 281 
increased toilet urgency. Further research is needed to better understand the extent to which 282 
physical activity barriers and facilitators differ among specific sub-groups (e.g., CD versus UC/IC; 283 
active disease versus inactive disease), as this will assist in the design and tailoring of physical 284 
activity interventions. 285 
 286 
A secondary objective of this study was to explore clinical and psychological correlates of fatigue. 287 
Fatigue is very common in IBD (29, 30). It is often associated with increased disease activity, pain, 288 
poor sleep quality, depression, and perceived stress (31). In the present study, fatigue was most 289 
prevalent in those with CD, females, those with high disease activity and those reporting lower levels 290 
of physical activity. Similar differences in prevalence of fatigue between CD and UC, gender and 291 
disease activity have been previously observed in a longitudinal study which, like ours, drew 292 
attention to patients with CD suffering more severe fatigue than those with UC, females being more 293 
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prone to it than males and fatigue levels increasing in line with disease severity (32). Another 294 
longitudinal study examined factors reducing fatigue and noted that regular exercise improved 295 
physical fatigue (33), corroborating our finding of fatigue being more prevalent in those reporting 296 
low levels of physical activity. In terms of predictors of fatigue, our adjusted models showed that 297 
both in CD and UC, anxiety and depression were associated with fatigue, which is consistent with the 298 
two previous longitudinal studies (32, 33) and the previous cross-sectional data summarised in a 299 
recent review (34). Graff et al. (32) explained this association by common pathways, and particularly 300 
pro-inflammatory cytokines contributing to mood changes, inflammation and fatigue, and 301 
neuroendocrine factors linking stress, inflammation and fatigue. Further, Graff et al. (32) also 302 
noticed that fatigue increases over time in IBD and that this process appears to be independent of 303 
disease activity, as some patients with inactive IBD also report significant levels of fatigue. In the 304 
present study, we observed a relationship between duration of illness (indicated by time since 305 
diagnosis) and fatigue in patients with CD. It is unclear why the same was not found in our 306 
participants with UC as that’s contrary to previous observations. Further to this, disease activity 307 
predicted fatigue in CD and not UC. This perhaps could be explained by generally lower levels of 308 
fatigue reported in UC. Interestingly, at the multivariable level, female gender explained fatigue in 309 
UC but not in CD. Females in general report higher levels of fatigue than males (35). The fact that 310 
gender did not predict fatigue in CD may thus have more to do with our sample (predominantly 311 
female) than the actual differences between CD and UC. These predictors of fatigue, and particularly 312 
anxiety and depression which we identified as common for both CD and UC, may suggest that 313 
therapies targeting mental symptoms may be useful in also addressing fatigue comorbid with IBD. 314 
Solution-focused therapy has shown promise (36), however there are very few interventional studies 315 
in the area and more needs to be done to propose effective therapies for fatigue in IBD. 316 
 317 
The strengths of this study include the use of a large clinically- and demographically-diverse sample 318 
and the exploration of a broad range of factors pertaining to physical activity. The limitations of this 319 
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study also need to be acknowledged. Firstly, as the data are cross-sectional, we cannot confirm the 320 
direction of relationships between physical activity, fatigue, and other disease and psychological 321 
variables. Secondly, the results might be prone to bias due to the exclusive use of self-reported data. 322 
For example, physical activity levels may have been under- or over-reported, and peoples’ disease 323 
activity may have been incorrectly categorised. Thirdly, the fact that participants for this survey were 324 
self-selected and predominantly recruited via social network advertisements means that the results 325 
might not be directly generalisable to the wider IBD population. Of particular note, around 75% of 326 
respondents were female meaning that the results might not be directly relevant to males.  327 
 328 
In summary, this large online survey has shown that the majority of respondents with IBD have low 329 
levels of physical activity. Associated factors included depression, disease activity and perceived 330 
barriers to exercise. A large proportion of respondents cited IBD-related limitations to physical 331 
activity such as pain, fatigue and increased toilet urgency. Given that regular physical activity may 332 
have numerous general and condition-specific benefits in people with IBD, attempting to increase 333 
participation of the IBD population in this vital health behaviour is probably a worthwhile pursuit. 334 
The results highlight several important factors that should be considered by designers of physical 335 
activity interventions for this population. Further research is now needed to better understand the 336 
barriers and facilitators of physical activity in specific sub-groups of patients, to determine the 337 
effects of different exercise programmes on important outcomes (e.g., fatigue, disease activity, and 338 
mental well-being), and to identify cost-effective interventions that have good potential for 339 
widespread implementation. Such efforts will help pave the way for the development of evidence-340 
based physical activity guidelines for people with IBD.   341 
 342 
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Figure Legends 440 
Figure 1 The most common types of physical activity/exercise that respondents participated 441 
in during the last year (Panel A) and avoided because of IBD (Panel B) 442 
Figure 2 Reasons given for IBD limiting participation in physical activity/exercise 443 
Figure 3 Average fatigue levels in the past two weeks (values in bars are %) 444 
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Table 1 Demographic and disease-related characteristics 452 
 CD  
(n = 446) 
UC/IC  
(n = 413) 
Total  
(n = 859) 
Age, mean (SD), years 36.9 (11.5) 37.7 (11.6) 37.3 (11.6) 
Female, n (%) 329 (73.8) 317 (76.8) 646 (75.2) 
Male, n (%) 117 (26.2) 96 (23.2) 213 (24.8) 
Employment status, n (%)    
Employed Full Time 192 (43.0) 232 (56.2) 424 (49.4) 
Employed Part Time 70 (15.7) 60 (14.5) 130 (15.1) 
Unemployed- Unable  83 (18.6) 39 (9.4) 122 (14.2) 
Unemployed- Other 32 (7.2) 25 (6.1) 57 (6.6) 
Student 55 (12.3) 36 (8.7) 91 (10.6) 
Retired 11 (2.6) 17 (4.1) 28 (3.3) 
Don’t know/ Prefer not to say 3 (0.7) 4 (1.0) 7 (0.8) 
Smoking Status, n (%)    
Yes 75 (16.8) 33 (8.0) 108 (12.6) 
No 278 (62.3) 293 (70.9) 571 (66.5) 
Not anymore 92 (20.6) 86 (20.8) 178 (20.7) 
Don’t Know/ Prefer not to say 1 (0.2) 1 (0.2) 2 (0.2) 
Time since diagnosis, median (IQR), monthsa 102 (36-188) 74.5 (36-168) 87 (36-178) 
Disease activity, n (%)a    
PRO3: Clinical Remission 119 (28.3)   
PRO3: Mildly Active 80 (19.0)   
PRO3: Moderately Active 190 (45.1)   
PRO3: Severely Active  32 (7.6)   
25 
 
P-SCCAI: Inactive  156 (40.7)  
P-SCCAI: Active  227 (59.3)  
CD, Crohn’s Disease; UC, Ulcerative Colitis; IC, Indeterminate Colitis; PRO3, 3-item Patient Reported 453 
Outcome (CD only); P-SCCAI, Patient-based Simple Clinical Colitis Activity Index (UC/IC only) 454 
 a5.6% (n = 25) CD respondents and 7.3% (n = 30) UC/IC respondents did not complete 455 
  456 
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Table 2 Clinical characteristics 457 
 CD  
(n = 421) 
UC/IC  
(n = 383) 
Total  
(n = 804) 
Current Treatment (%)a 
Oral 5-Aminosalicytes 
Corticosteroids 
Immunosuppressants 
Antibiotics 
Anti-Diarrheals 
Pain Relief 
Iron Supplements 
Vitamin B-12 Injections 
Calcium Supplements 
Vitamin D Supplements 
Nutrition Therapy 
No Medication Required 
Don’t Know/ Prefer not to say 
Other 
 
95 (23.3) 
83 (20.4) 
262 (63.7) 
23 (5.5) 
83 (19.7) 
163 (38.7) 
85 (20.2) 
111 (26.4) 
94 (22.3) 
139 (33.0) 
 15 (3.6) 
20 (4.8) 
3 (0.7) 
66 (15.7) 
 
196 (54.0) 
79 (21.7) 
147 (38.6) 
17 (4.4) 
71 (18.5) 
99 (26.1) 
67 (17.5) 
N/A 
N/A 
N/A 
N/A 
27 (7.3) 
5 (1.3) 
62 (16.2) 
 
291 (37.9) 
162 (21.0) 
409 (51.7) 
40 (4.9) 
154 (19.2) 
262 (32.7) 
152 (18.9) 
111 (13.8) 
94 (11.7) 
139 (17.3) 
15 (1.9) 
47 (6.0) 
8 (1.0) 
128 (15.9) 
Surgical History (%)a 
Permanent Ileostomy  
Temporary Ileostomy 
Permanent Colostomy 
Temporary Colostomy 
Strictureplasty 
Resection 
 
27 (6.4) 
38 (9.0) 
13 (3.1) 
7 (1.7) 
24 (5.7) 
111 (26.4) 
 
27 (7.0) 
43 (11.2) 
29 (7.6) 
3 (0.8) 
N/A 
N/A 
 
54 (6.7) 
81 (10.1) 
42 (5.2) 
10 (1.2) 
24 (3.0) 
111 (13.8) 
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Ileocaecal Resection 
Limited Right Hemicolectomy 
Proctocolectomy 
Ileo-Anal Pouch 
I have not had surgery 
Don’t know/ Prefer not to say 
Other 
49 (11.6) 
32 (7.6) 
15 (3.6) 
N/A 
203 (48.2) 
2 (0.5) 
62 (14.7) 
N/A 
N/A 
N/A 
54 (14.1) 
283 (73.9) 
1 (0.3) 
21 (5.5) 
49 (6.1) 
32 (4.0) 
15 (1.9) 
54 (6.7) 
486 (60.4) 
3 (0.4) 
83 (10.3) 
Time Since Last Surgery, median (IQR), months 36 (16-96) 36 (12-84) 36 (13-84) 
CD, Crohn’s Disease; UC, Ulcerative Colitis; IC, Indeterminate Colitis 458 
a5.6% (n = 25) CD respondents and 7.3% (n = 30) UC/IC respondents did not complete   459 
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Table 3 Physical activity, depression and anxiety data by disease type and activity 
 Total  
(n = 834) 
 CD 
(n = 421) 
 UC/IC 
(n = 413) 
   Clinical 
remission 
Mildly  
active 
Moderately 
active 
Severely 
active 
 Inactive 
 
Active 
IPAQ Category (%)a          
HEPA active 17.1  21.5 23.2 10.4 3.4  21.2 17.8 
Minimally active 49.6  51.4 55.1 48.6 34.5  57. 6 44.1 
Inactive 33.3  27.1 21.7 41.0 62.1  21.2 38.1 
IPAQ MVPA, median (IQR), 
MET·min/weeka 
360 
(0-1875) 
 960  
(0-2120) 
720 
(0-2040) 
0 
(0-1380) 
0 
(0-410) 
 820 
(0-2160) 
120 
(0-1440) 
IPAQ Total PA, median (IQR), 
MET·min/weekab 
1866 
(594-4040) 
 2222 
(1205-4584) 
2730 
(1158-4986) 
1386 
(996-3412) 
600 
(60-2079) 
 2355 
(983-4650) 
1386 
(446-3465) 
IPAQ Sitting, mean (SD), min/daya 429 (225)  369 (177) 416 (220) 444 (254) 561 (317)  410 (202) 445 (214) 
EBBS Barriers Score, mean (SD)c 31.6 (6.6)  29.8 (7.0) 31.5 (6.6) 33.4 (5.4) 34.2 (7.0)  30.2 (6.4) 31.7 (6.8) 
EBBS Benefits Score, mean (SD) c 84.9 (15.3)  87.8 (14.3) 83.0 (20.3) 81.2 (13.6) 80.1 (15.8)  88.0 (15.0) 86.4 (14.9) 
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HADS Anxiety, mean (SD) 9.1 (4.5)  7.3 (4.1) 8.9 (4.3) 11.4 (4.1) 12.4 (3.7)  6.8 (4.1) 9.6 (4.3) 
HADS Depression, mean (SD) 7.0 (4.3)  4.8 (3.4) 6.7 (4.2) 9.2 (4.1) 11.3 (3.7)  4.5 (3.5) 7.8 (4.1) 
CD, Crohn’s Disease; UC, Ulcerative Colitis; IC, Indeterminate Colitis; IPAQ, International Physical Activity Questionnaire; EBBS, Exercise Benefits/Barriers 
Scale; HADS, Hospital Anxiety and Depression Scale; MVPA, Moderate-to-Vigorous Physical Activity 
a10.2% (n = 43) CD respondents and 19% (n = 79) UC/IC respondents did not complete 
bTotal physical activity computed as the sum of Walking + Moderate + Vigorous MET·min/week scores 
c14% (n = 59) CD respondents and 23.7% (n = 98) UC/IC respondents did not complete 
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Table 4 Correlation matrix between physical activity and fatigue (composite) scores and various 
demographic, clinical and psychological factors 
 Physical activitya  Fatigue 
 CD UC/IC  CD UC/IC 
Age -0.098 -0.158**  0.036 -0.070 
Time since diagnosis -0.042 -0.064  0.110* 0.017 
Disease activity -0.228** -0.123*  0.479** 0.393** 
Depression -0.287** -0.240**  0.538** 0.572** 
Anxiety -0.120* 0.049  0.465** 0.453** 
Physical activity - -  -0.127* -0.181** 
Fatigue -0.127* -0.181**  - - 
Exercise benefits 0.244** 0.171**  N/A N/A 
Exercise barriers -0.292** -0.112  N/A N/A 
CD, Crohn’s disease; IC, Indeterminate Colitis; UC, Ulcerative Colitis 
aTotal physical activity computed as the sum of Walking + Moderate + Vigorous MET·min/week 
scores (logarithmic transformed) 
*Correlation is significant at the 0.05 level  
**Correlation is significant at the 0.01 level 
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Table 5 Regression model results for total physical activity (logarithmic transformed) 
 Crohn’s Disease  Ulcerative and Indeterminate Colitis 
 B Std. 
Error 
Beta t P-value Adjusted 
R2 
 B Std. 
Error 
Beta t P-value Adjusted 
R2 
First Modela              
(Constant) 8.015 0.862  9.299 <0.001 0.132  7.685 0.609  12.611 <0.001 0.076 
Age N/A N/A N/A N/A N/A   -0.016 0.006 -0.146 -2.566 0.011  
Gender 0.216 0.155 0.074 1.393 0.165   0.000 0.168 0.097 1.676 0.095  
Disease activity -0.010 0.005 -0.130 -2.083 0.038   -0.053 0.027 -0.001 -0.010 0.992  
Depression -0.077 0.024 -0.251 -3.199 0.002   -0.053 0.024 -0.177 -2.252 0.025  
Anxiety 0.034 0.021 0.114 1.576 0.116   N/A N/A N/A N/A N/A  
Fatigue 0.024 0.018 0.086 1.294 0.197   -0.013 0.019 -0.049 -0.671 0.503  
Exercise benefits 0.007 0.006 0.081 1.238 0.216   0.005 0.005 0.062 0.993 0.321  
Exercise barriers -0.035 0.013 -0.171 -2.655 0.008   N/A N/A N/A N/A N/A  
Second Modelb              
(Constant) 9.437 0.342  27.563 <0.001 0.123  8.505 0.247  34.439 <0.001 0.073 
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Age N/A N/A N/A N/A N/A   -0.015 0.006 -0.145 -2.636 0.009  
Disease activity -0.009 0.005 -0.109 -1.873 0.062   N/A N/A N/A N/A N/A  
Depression -0.048 0.019 -0.157 -2.563 0.011   -0.069 0.016 -0.232 -4.216 <0.001  
Exercise barriers -0.043 0.011 -0.212 -3.847 <0.001   N/A N/A N/A N/A N/A  
aIncluding only those variables that were significantly correlated with physical activity in the initial exploratory work (correlation matrices) 
bIncluding only those variables that were statistically significant in the First Model  
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Table 6 Regression model results for fatigue (composite score) 
 Crohn’s Disease  Ulcerative and Indeterminate Colitis 
 B Std. 
Error 
Beta t P-value Adjusted 
R2 
 B Std. 
Error 
Beta t P-value Adjusted 
R2 
First Modela              
(Constant) 0.380 1.549  0.245 0.806 0.367  4.512 1.547  2.917 0.004 0.373 
Gender  -0.649 0.473 -0.062 -1.373 0.171   -1.360 0.495 -0.125 -2.744 0.006  
Time since 
diagnosis 
0.005 0.002 0.112 2.550 0.011   N/A N/A N/A N/A N/A  
Disease activity 0.083 0.014 0.287 5.772 <0.001   0.152 0.081 0.098 1.884 0.061  
Depression 0.278 0.070 0.251 3.982 <0.001   0.454 0.070 0.408 6.455 <0.001  
Anxiety 0.226 0.063 0.211 3.554 <0.001   0.180 0.061 0.172 2.969 0.003  
Physical activity 0.163 0.163 0.045 0.996 0.320   -0.253 0.180 -0.068 -1.405 0.161  
Second Modelb              
(Constant) 1.172 0.503  2.328 0.020 0.370  3.320 0.727  4.565 <0.001 0.360 
Gender N/A N/A N/A N/A N/A   -1.476 0.455 -0.133 -3.242 0.001  
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Time since 
diagnosis 
0.003 0.002 0.083 2.111 0.035   N/A N/A N/A N/A N/A  
Disease activity 0.076 0.013 0.270 6.102 <0.001   N/A N/A N/A N/A N/A  
Depression 0.324 0.060 0.295 5.375 <0.001   0.517 0.057 0.465 9.148 <0.001  
Anxiety 0.183 0.056 0.170 3.237 0.001   0.178 0.054 0.168 3.312 0.001  
aIncluding only those variables that were significantly correlated with fatigue in the initial exploratory work (correlation matrices) 
bIncluding only those variables that were statistically significant in the First Model 
